Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 31.9% | 23.8% | |
| Net result | €38k | €3k | |
| Equity | €253k | €16k | |
| Gross operating margin | €246k | €15k | |
| Staff costs | €103k | €23k |
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €100k |
| Net profit | €38k |
| Cash flow | €82k |
| Staff costs | €103k |
| Income taxes | €14k |
| Dividends | — |
| Total assets | €792k |
| Equity | €253k |
| Debt | €539k |
| of which ≤ 1y | €523k |
| of which > 1y | €16k |
| Working capital | €158k |
| Employees (FTE) | 3.0 |
| 2024 | |
|---|---|
| Current ratio | 1.30 |
| Quick ratio | 0.55 |
| Working capital ratio | 19.9% |
| Solvency | 31.9% |
| Debt / equity | 2.13 |
| Long-term debt ratio | 0.06 |
| Interest coverage | 16.30 |
| Gross margin | — |
| Net margin | — |
| ROA | 4.8% |
| ROE | 15.1% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €792k |
| Fixed assets | 21/28 | €111k |
| Tangible fixed assets | 22/27 | €100k |
| Financial fixed assets | 28 | €12k |
| Current assets | 29/58 | €681k |
| Stocks & contracts in progress | 3 | €393k |
| Amounts receivable within one year | 40/41 | €261k |
| Investments | 50/53 | €24k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €792k |
| Equity | 10/15 | €253k |
| Contributions / capital | 10/11 | €2k |
| Accumulated profits (losses) | 14 | €251k |
| Amounts payable | 17/49 | €539k |
| Amounts payable after one year | 17 | €16k |
| Amounts payable within one year | 42/48 | €523k |
| Trade debts payable within one year | 44 | €314k |
| Income statement | ||
| Gross operating margin | 9900 | €246k |
| Operating result | 9901 | €57k |
| Financial income | 75 | €329 |
| Financial charges | 65 | €6k |
| Result before taxes | 9903 | €52k |
| Income taxes | 67/77 | €14k |
| Net result for the period | 9904 | €38k |
| Result to be appropriated | 9905 | €38k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →